favipiravir has been researched along with Exanthema* in 1 studies
1 other study(ies) available for favipiravir and Exanthema
| Article | Year |
|---|---|
COVID-19 and favipiravir induce cutaneous adverse reactions: a difficulty in clinical dermatology practice.
There have been reports of skin rash developing in patients with COVID-19 on favipiravir therapy, including a recent report in this journal. We report a patient who developed a maculopapular skin rash while taking favipiravir. Topics: Amides; Antiviral Agents; COVID-19 Drug Treatment; Dermatology; Exanthema; Humans; Pyrazines | 2022 |